Life expectancy at birth in the United States reflects the average number of years a newborn is expected to live if current mortality rates remain constant throughout their life. It is a population-level summary of survival rather than a prediction for any individual. In the U.S., life expectancy at birth has risen substantially over the twentieth century due to public health advances, vaccinations, antibiotics, and declining child mortality, but has flattened and declined slightly in the twenty-first century. Recent years have seen modest rebounds following pandemic-era declines, though levels remain below pre-pandemic peaks. This article explains how the metric is defined, how it is calculated, recent trends, differentials across groups, and the social, economic, and health factors shaping it over time.
How Life Expectancy at Birth Is Defined and Calculated
Life expectancy at birth is a demographic measure derived from age-specific death rates in a given year. It represents the average number of years a hypothetical cohort would live if each experienced the age-specific death rates of a reference year throughout their lives. Key notes include:
- It is a period measure, not a forecast for any specific person.
- It is highly sensitive to infant and child mortality, as well as deaths at younger adult ages.
- It can change even without new medical breakthroughs, due to shifts in injuries, poisonings, chronic disease, or public health crises.
In the United States, the National Center for Health Statistics (NCHS), part of the Centers for Disease Control and Prevention (CDC), produces annual life expectancy estimates using death counts from state vital records and population estimates from the U.S. Census Bureau. International comparisons commonly use data from the World Bank, the United Nations, or the Human Mortality Database to place U.S. trends in a broader context.
Recent Trends and Levels
Over the long term, life expectancy at birth in the U.S. increased for most of the twentieth century and into the early 2010s. Since then, progress has slowed, and the country has experienced several reversals. Key phases include:
| Period | Approximate Life Expectancy at Birth (years) | Notes |
|---|---|---|
| 1950–1960 | ~69.5–70.2 | Postwar public health improvements |
| 1970 | ~70.8 | Continued decline in infant mortality |
| 1990 | ~75.2 | Declines in cardiovascular disease mortality |
| 2010 | ~78.7 | Peak in the modern era before declines |
| 2014–2016 | ~78.9 | Slight increases driven by falling drug overdose death rates |
| 2020 | ~77.0 | Historic decline driven largely by the COVID-19 pandemic |
| 2021 | ~76.6 | Preliminary continued decline |
| 2022 | ~77.5 | Rebound from 2021 lows, still below pre-pandemic levels |
| 2023 (provisional) | ~77.5–77.9 | Signals stabilization and partial recovery, but remains below 2019 |
These figures illustrate that while U.S. life expectancy at birth has generally trended upward over decades, the last several years have been marked by notable volatility due to the pandemic, drug overdose deaths, and shifting mortality from other causes.
Disparities by Race, Ethnicity, and Gender
Life expectancy at birth differs across racial, ethnic, and gender groups in the United States. These disparities reflect structural determinants of health, including access to care, neighborhood conditions, employment, education, and exposure to violence and environmental harms. Highlights include:
- Non-Hispanic Black populations have historically experienced lower life expectancy compared to non-Hispanic White populations, with gaps fluctuating over time but remaining substantial.
- Hispanic and some Asian and other populations have, at times, shown higher life expectancy at birth compared to White populations, a pattern sometimes referred to as the Hispanic mortality paradox.
- Differences by gender show that females generally have higher life expectancy at birth than males, though gaps have narrowed over time.
Because these differentials are rooted in social determinants and structural inequities, changes at the population level often affect disadvantaged groups differently, reshaping the overall national estimate.
Key Drivers and Determinants
Life expectancy at birth is influenced by a broad set of factors, including but not limited to medical care, behaviors, social conditions, and policy. Important categories include:
| Domain | Examples of Factors | Influence on Life Expectancy at Birth |
|---|---|---|
| Public Health and Healthcare | Vaccination, cancer screening, management of hypertension and diabetes | Reduces preventable deaths and improves survival with chronic conditions |
| Behaviors and Injuries | Tobacco use, diet, physical activity, drug overdoses, motor vehicle crashes | Major contributors to years of life lost in working-age adults |
| Social Determinants | Poverty, education, housing quality, employment, incarceration | Shape access to care and exposures to health risks |
| Environment and Policy | Air and water quality, gun policy, paid family and medical leave, safety regulations | Influence chronic disease risk and injury mortality |
| Epidemics and External Shocks | Pandemics, drug overdose epidemics, economic crises | Can cause abrupt, multigenerational changes |
No single factor determines U.S. life expectancy at birth; rather, it is the product of complex interactions among healthcare system performance, social and economic policy, and individual circumstances. Improvements in one domain can be offset by worsening conditions in another, which explains periods of stagnation or decline even in the presence of medical advances.
International Comparisons and Context
Life expectancy at birth in the United States generally ranks below that of many other high-income countries despite high per-person spending on healthcare. Key contextual points include:
- Countries with universal health coverage and broader social safety nets often show higher life expectancy at birth.
- U.S. mortality from preventable conditions and maternal mortality remain relatively elevated compared with peer nations.
- Neighboring countries such as Canada, as well as many European and East Asian nations, routinely report higher life expectancy at birth, highlighting the role of structural factors beyond clinical care.
These comparisons underscore that life expectancy at birth is shaped not only by medical care but also by broader social, economic, and environmental contexts.
Data Sources, Limitations, and Responsible Interpretation
Key U.S. sources for life expectancy at birth include the National Center for Health Statistics (NCHS) and the Human Mortality Database. International comparisons commonly draw on United Nations and World Bank datasets. Important limitations to keep in mind:
- Life expectancy at birth is sensitive to early-life mortality; small changes in infant deaths can substantially shift the figure.
- It is a period measure and does not guarantee how long members of a current cohort will actually live.
- Data lags by 1–2 years; recent changes may be revised as complete data become available.
- Analyses that compare groups must account for age structure and other demographic differences to avoid misleading conclusions.
When interpreting estimates, it is best to examine trends over time, compare like-with-like across populations, and consider the multiple social and health drivers rather than treating a single year’s figure as definitive.
Outlook and Public Health Implications
Going forward, life expectancy at birth in the U.S. will be shaped by continued investments in public health, equitable access to care, injury prevention, and policies that address social determinants of health. The rebound from pandemic losses represents progress but does not yet restore pre-pandemic levels. Sustained efforts to reduce preventable deaths, address overdose and mental health crises, improve chronic disease management, and reduce inequities across communities will influence whether the next decade brings renewed gains or further stagnation. As new data emerge, periodic updates to this baseline understanding will remain essential for both researchers and policymakers.
Conclusion
Life expectancy at birth in the United States captures a moment in time that reflects medical, social, and economic conditions. It has risen over the long term but has recently experienced volatility due to external shocks and underlying inequities. Current estimates indicate a modest recovery in recent years, though levels remain below pre-pandemic baselines. Understanding the definition, limitations, and drivers of this metric helps clarify what it means and how it evolves. Continued focus on public health, social policies, and equitable care will shape future trajectories for life expectancy at birth in the U.S.